Ll. Mickleborough et al., ARE PATIENTS RECEIVING AMIODARONE AT INCREASED RISK FOR CARDIAC OPERATIONS, The Annals of thoracic surgery, 58(3), 1994, pp. 622-629
Amiodarone therapy has been implicated as a risk factor for cardiothor
acic surgical procedures. In patients undergoing map-guided surgical p
rocedures for the treatment of ventricular tachycardia, we compared th
e perioperative course of those receiving long-term amiodarone therapy
(n = 36) versus that in those not receiving the drug (n = 31). The tw
o groups were similar with respect to age, sex, presenting symptoms, f
unctional class, extent of coronary artery disease, presence of a vent
ricular aneurysm, technique of ventricular tachycardia ablation, cross
-clamp or pump time, the number of vessels grafted, the operative flui
d balance, and a need for intraaortic balloon pump or inotropic agent
support. In 5 patients receiving amiodarone, epinephrine was required
to maintain a normal systemic vascular resistance and adequate arteria
l pressure. Postoperatively, 6 patients (17%) on amiodarone therapy su
ffered acute respiratory failure. In spite of aggressive therapy, 3 of
these patients died. Only 1 patient not receiving amiodarone died of
a stroke. We conclude that amiodarone therapy in patients undergoing o
pen heart operations is associated with an increased risk of severe pu
lmonary complications (p = 0.03 by Fisher's exact test). Amiodarone th
erapy should be withheld in patients with ventricular tachycardia unti
l they have been assessed as candidates for possible surgical interven
tion.